Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 476,784 | 429,485 | 502,069 | 454,443 | 461,097 |
| Cost of Goods | 188,793 | 97,967 | 111,374 | 95,899 | 96,949 |
| Gross Profit | 287,991 | 331,518 | 390,695 | 358,544 | 364,148 |
| Operating Expenses | 344,725 | 373,430 | 286,108 | 368,605 | 361,087 |
| Operating Income | -55,941 | -40,945 | 104,961 | -9,162 | 4,010 |
| Interest Expense | 9,597 | 8,048 | 6,915 | 6,930 | 2,937 |
| Other Income | 4,322 | 6,720 | 3,306 | 6,311 | 8,749 |
| Pre-tax Income | -61,216 | -42,273 | 101,352 | -9,781 | 9,822 |
| Income Tax | -846,019 | -13,090 | 19,971 | -24,805 | -45,214 |
| Net Income Continuous | 784,803 | -29,183 | 81,381 | 15,024 | 55,036 |
| Net Income | $784,803 | $-29,183 | $81,381 | $15,024 | $55,036 |
| EPS Basic Total Ops | 4.33 | -0.16 | 0.45 | 0.09 | 0.31 |
| EPS Basic Continuous Ops | 4.33 | -0.16 | 0.45 | 0.09 | 0.31 |
| EPS Diluted Total Ops | 4.01 | -0.16 | 0.44 | 0.10 | 0.30 |
| EPS Diluted Continuous Ops | 3.97 | -0.16 | 0.43 | 0.10 | 0.30 |
| EBITDA(a) | $-29,170 | $-15,751 | $130,985 | $16,525 | $34,362 |